Date: 10 – 11 October 2024
Place: Bern
Language: English
Registration deadline single module: 4 October 2024 Registration
Fee: two-day module CHF 500, single-day booking CHF 280
Credits:
1 ECTS point two-day module
12 CME points “Schweizerische Gesellschaft für Medizinische Onkologie”
12 CME points “Schweizerische Gesellschaft für Chirurgie”
Goals of the module
Participants
- have an overview on sex differences in oncology and the scientific, clinical and societal implications of sex differences for prevention, diagnosis and treatment of cancer.
- are familiar with the combined impact of sexual hormones and sex chromosomes on cancer susceptibility with a focus on intrinsic control of cancer initiating cell populations, tumor microenvironment and systemic determinants of cancer development.
Content of the module
- Rationale for considering sex and gender in cancer prevention and treatment
-
-
- Sex differences in epidemiology of various cancers
- Sex and gender differences in carcinogen exposition (UV light, smoking, environmental carcinogens)
-
-
- Sex chromosomes and their impact on cancer susceptibility
-
- Estrogens and their impact on cancer risk in females and males
- Endocrine disruptors
- Androgens and their impact on cancer risk in females and males
-
- Impact of sex on systemic determinants of cancer development
- immunity
- tumor microenvironment
- cancer initiating cells
- metabolism
- microbiome
-
- Clinical implications of sex and gender differences in cancer
- Sex differences in response and toxicity of anticancer therapies (cytotoxics, targeted therapies and immunotherapies)
- Sex differences in oncological surgery and radiotherapy outcomes
- Implications for clinical trial design and reporting of results
- Sex-specific drug dosing strategies?
- Sex-specific cancer prevention efforts?
- Clinical implications of sex and gender differences in cancer